ARTICLE | Company News
GTx, Tessera Inc deal
August 2, 2004 7:00 AM UTC
The companies partnered to develop a blood or urine test for high-grade prostatic intraepithelial neoplasia (PIN). GTXI will provide clinical samples from its completed Phase IIb trial of Acapodene t...